Systemic sclerosis with renal crisis and pericardial effusion

Area of Science:

• Nephrology
• Rheumatology
• Cardiology

Background:

• Scleroderma renal crisis (SRC) affects 10% of systemic sclerosis patients, presenting a poor prognosis.
• SRC is characterized by thrombotic microangiopathy (TMA) on kidney biopsy, requiring differentiation from other TMAs.
• Systemic sclerosis can also cause pericardial effusion and tamponade physiology.

Purpose of the Study:

• To summarize the clinical presentation and management of scleroderma renal crisis.
• To highlight the diagnostic criteria and prognostic implications of SRC.
• To discuss associated cardiac complications in systemic sclerosis patients.

Main Methods:

• Review of literature on scleroderma renal crisis and associated complications.
• Analysis of clinical findings differentiating SRC-TMA from other TMAs.
• Discussion of emergent interventions for renal and cardiac involvement.

Main Results:

• SRC occurs in 10% of systemic sclerosis patients, often with poor outcomes.
• Kidney biopsies show TMA, necessitating distinction from other TMA causes.
• Fifty percent of patients progress to end-stage renal disease (ESRD), requiring dialysis.
• Cardiac tamponade is a potential complication requiring pericardiocentesis.

Conclusions:

• Scleroderma renal crisis is a serious complication of systemic sclerosis with significant renal and cardiac implications.
• Early recognition and intervention are crucial for managing SRC and its complications like ESRD and cardiac tamponade.
• Multidisciplinary management is essential for patients with systemic sclerosis and renal or cardiac involvement.